Drugs / BMN 333
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07441876 | Apr 2026 → Jun 2029 expected | achondroplasia | BioMarin Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMN 333 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07441876 ↗ |
| Route | Subcutaneous | “Administration: Weekly subcutaneous injection” NCT07441876 ↗ |